7 Recruiting Trials

Clinical Trials for Multiple Sclerosis in Virginia

7 clinical trials for Multiple Sclerosis are currently recruiting participants at study sites in Virginia. Study-related care is provided at no cost.

Showing 7 of 7 recruiting Multiple Sclerosis trials in Virginia

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
PHASE4 New Haven, Connecticut +4 sites NCT05285891
Recruiting

Multiple Sclerosis clinical trials in Virginia: common questions

How many Multiple Sclerosis clinical trials are recruiting in Virginia?
TrialFinder currently lists 7 recruiting Multiple Sclerosis clinical trials with study sites in Virginia. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Multiple Sclerosis clinical trials located in Virginia?
Sites for these Multiple Sclerosis trials are spread across Virginia. Open any trial to see its full list of participating locations and contact details.
Do I need insurance to join a Multiple Sclerosis clinical trial in Virginia?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Multiple Sclerosis trials in Virginia also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Multiple Sclerosis clinical trial in Virginia?
Each study sets its own criteria based on age, Multiple Sclerosis diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Multiple Sclerosis trials near you in Virginia.

Get Matched — Free
No insurance required

MS trials investigate disease-modifying therapies, remyelination strategies, stem-cell transplants, and neuroprotective agents for relapsing and progressive forms of MS.

All Multiple Sclerosis trials →